BIONEVIA PHARMACEUTICALS INC has a total of 35 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are TIANJIN TASLY GROUP CO LTD, PREXTON THERAPEUTICS SA and CARDERO THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | United States | 6 | |
#4 | EAPO (Eurasian Patent Organization) | 4 | |
#5 | Australia | 2 | |
#6 | Canada | 2 | |
#7 | Hungary | 2 | |
#8 | Brazil | 1 | |
#9 | China | 1 | |
#10 | United Kingdom | 1 | |
#11 | Hong Kong | 1 | |
#12 | Serbia | 1 | |
#13 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Kalofonos Isabel | 35 |
#2 | Martin-Doyle William | 34 |
#3 | Kalofonos Dimitris | 28 |
#4 | Stults Jeffrey S | 26 |
#5 | Stahly G Patrick | 22 |
#6 | Houston Travis L | 17 |
#7 | Hanko Jason A | 10 |
#8 | Caron Judy | 6 |
#9 | Shipplett Rex A | 6 |
#10 | Stahly Patrick G | 4 |
Publication | Filing date | Title |
---|---|---|
US2014221438A1 | Solid forms of epalrestat | |
EP2665477A1 | Modified release compositions of epalrestat or a derivative thereof and methods for using the same | |
WO2010081070A2 | Novel forms of eperisone | |
US2010069389A1 | Novel forms of reboxetine | |
AU2009288037A1 | Novel choline cocrystal of epalrestat | |
BRPI0916889A2 | compound, pharmaceutical composition, and methods for treating pain, for treating a disorder or disease, and for making a co-crystal | |
WO2010017135A2 | Novel forms of eperisone | |
EA018905B1 | A novel betaine cocrystal of epalrestat | |
EA018600B1 | Novel crystalline salts of epalrestat | |
WO2009152347A2 | Crystalline forms of zotepine hydrochloride |